Cancer Research Institute

🎉 Congratulations @sidichen the 2025 KCA-CRI Clinic & Laboratory Integration Program (CLIP) Investigator! We were proud to partner with @CancerResearch on a kidney-specific award. We spoke with Chen in detail about his research 👉 read more bit.ly/4f00UaK

"According to the Cancer Research Institute’s “2025 Cancer Immunotherapy Insights + Impact Report,” the FDA has approved more than 150 immunotherapies since 2011, granting 17 immunotherapy approvals in 2024 alone," @BeckersHR describes. Learn more: bit.ly/45fdwYm

I am delighted to share that I have been selected as the next @CancerResearch Cinelli Family Foundation Postdoctoral Fellow, a special designation for the most promising early-career scientists in the CRI community. I want to thank @Lo_Zanzi, who supports me day by day (1/3)

"Having a grant specifically focused on kidney cancer allows us to take risks, innovate, and push boundaries in ways that general funding might not support," emphasizes CRI-@KidneyCancer CLIP Investigator Dr. Sidi Chen @YaleMed. Read more: bit.ly/4f00UaK #KidneyCancer

“STING turns out to have a unique and unexpected role in these intestinal-resident immune cells, and we think it could be a target for future therapies for gut inflammation,” describes CRI Lloyd J. Old STAR Dr. Sonnenberg @WeillCornell. Learn more: bit.ly/40jfQuw

How effective is sunscreen in preventing cancer, and what form of sunscreen is best to use? This summer, gain answers to your most frequently asked skin cancer prevention questions, from an expert at @HarvardChanSPH: bit.ly/4kpWCuw #SkinCancer #SkinCancerPrevention

What are the possible side effects of immunotherapy, and how will I know if my immunotherapy treatment is working? Gain answers to your most frequently asked immunotherapy questions, in Hope in Action: A Patient’s Guide to Cancer #Immunotherapy: bit.ly/4k4egne

Can new blood tests really detect cancer early? Explore a study that seeks to understand how the tests perform in comparison to more conventional cancer screening, and whether these tests are ready for patients, with @washingtonpost: wapo.st/3GOohrh #EarlyDetection

Explore progress in the treatment of gastrointestinal cancers, as discussed during #ASCO25, according to @RutgersCancer's Dr. Boland, in @TargetedOnc: bit.ly/4lf901v #CancerResearch #ASCO #Immunotherapy

Researchers @PennMedicine and @nyutandon, including CRI Postdoctoral Fellow Dr. Chao Ma, have developed a miniature device that could transform how blood cancer treatments are tested and tailored to patients. Explore with @UofPenn: bit.ly/3G8zJ0J #Immunotherapy

🧪 Explore the history of cancer immunotherapy over the last 100+ years, from early observations to modern breakthroughs, and discover its transformative ability in the fight against cancer, in The History of Cancer Immunotherapy: bit.ly/43XlHIr #Immunotherapy

Congrats to Dr. Ke Pan of MD Anderson for being the newest grantee jointly funded by our partnership with @CancerResearch! His project aims to lay the groundwork for a new, brachyury-targeting immunotherapy strategy that could hold promise for chordoma patients. More:…

Family or personal history, exposure to chemicals like industrial tar, and smoking are all considered risk factors for skin cancer, @RoswellPark describes. Although all these factors influence our risk, sun damage is the leading cause: bit.ly/46xTp8S #SkinCancer

Congratulations to @BraunMDPhD + @sidichen for being named Clinical Laboratory Integration Program (CLIP) awardees by @CancerResearch! CLIP supports early-phase studies that test the translational potential of new immunotherapy approaches. medicine.yale.edu/news-article/d… @SmilowCancer…

Thank you @CancerResearch for this opportunity to study how EMT alters the immune properties and immunotherapy response of RCC. Grateful to my mentors and collaborators @uvaurology @UMichUrology and very thankful to CRI for this crucial support!

Grateful and honored to receive the CLIP award from @CancerResearch . This support will enable us to investigate the biology of MDSCs, and to develop novel immunotherapies targeting these cells in glioblastoma. Thank you to CRI for supporting our work—excited for what’s ahead!

Congratulations to @DukeCancer faculty Dr. Yubin Kang for his new @CancerResearch CLIP award studying how targeting SK2 can enhance CAR T cell therapy efficacy in multiple myeloma #mmsm cancerresearch.org/wp-content/upl…